Received: 10 May 2026
Accepted: 03 September 2026
Published online: 30 October 2026
UDC: 615.276(574)
DOI: 10.53511/pharmkaz.2026.5.20
Article type: Original Research Article
STRUCTURE OF REGISTERED IBUPROFEN-CONTAINING MEDICINAL PRODUCTS AND ANALYSIS OF MAXIMUM RETAIL PRICES IN THE REPUBLIC OF KAZAKHSTAN: A DESCRIPTIVE STUDY OF THE STATE REGISTER
Andassova A.G.1, Tleubayeva M.I.1, Yeshenkulova G.I.2
1NAO “S.D.Asfendiyarov Kazakh National Medical University”, Almaty, Kazakhstan
2Astana IT University, Astana, Kazakhstan
Introduction: To analysis of the structure of ibuprofen-containing medicinal products registered in the Republic of Kazakhstan by country of manufacture, dosage form, strength, and approved maximum retail price.
Materials and methods. A descriptive study was conducted using data from the State Register of Medicinal Products of the Republic of Kazakhstan and official information on maximum retail prices approved by the authorized governmental body. A descriptive analysis of the structure of medicinal products and a comparative analysis of registered products were performed. Data from the State Register were analyzed as of February 16, 2026, while data on maximum retail prices were analyzed as of January 5, 2026.
Results and discussion. Sixty-nine registration entries for ibuprofen-containing medicinal products were identified in the State Register. Most registered products are manufactured by foreign pharmaceutical companies. According to the study results, suspensions accounted for the largest share (36.2%), followed by tablets (31.9%) and capsules (14.5%). Differences in maximum retail prices were observed depending on the manufacturer, dosage form, strength, and package size. The price analysis was conducted for 13 registration entries for which price data were available. To compare medicinal products with different dosages, their prices were recalculated to an equivalent of 400 mg of ibuprofen. The unit of analysis in the study is a registration entry, defined as a unique combination of trade name, dosage form, strength, and packaging.
Conclusion. The study results characterize the structure of ibuprofen-containing medicinal products registered in the Republic of Kazakhstan and enable their systematization by country of manufacture, dosage form, and approved maximum retail price. The obtained results may be used for monitoring registered medicinal products and conducting further pharmacoeconomic studies.
Keywords: Ibuprofen, medicinal products, State Register of Medicinal Products, maximum retail price, comparative analysis.
количество просмотров / 👁 142